BRCA1 or BRCA2 mutations correlate with improved survival and platinum sensitivity in ovarian cancer
BRCA Mutations Linked to Better Ovarian Cancer Survival
This systematic review examines the impact of BRCA1 and BRCA2 mutation status on treatment outcomes in ovarian cancer patients. The review f…
Women with ovarian cancer and BRCA mutations may live longer and respond better to certain treatments, a review finds.
Molecular drivers including DNA damage response and epigenetics contribute to treatment resistance in HPV-positive OPSCC
Understanding the Molecular Causes of Treatment Resistance in Throat Cancer
This systematic review examines the molecular architecture of treatment resistance in patients with HPV-positive oropharyngeal squamous cell…
Doctors are looking into why some throat cancers do not respond to standard treatments like radiation and chemotherapy.
Combination Therapies Improve Progression Free Survival in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Combination therapies show promise for advanced head and neck cancer
This meta-analysis evaluated combination therapies involving targeted agents or immunotherapy with chemotherapy for patients with recurrent …
Combining immunotherapy or targeted drugs with chemotherapy may help patients with advanced head and neck cancer live longer without the dis…
Integrative therapy with traditional Chinese medicine reduces adverse events and improves immune markers in postoperative ovarian cancer patients receiving platinum-based chemotherapy
Adding This One Step After Surgery May Reduce Chemo Side Effects
A systematic review and meta-analysis of 1,719 patients found that adding traditional Chinese medicine to platinum-based chemotherapy signif…
Women who added traditional Chinese medicine to their post-surgery chemo saw nearly 50 percent fewer side effects and stronger immune recove…
Review examines thoracic radiotherapy combined with chemoimmunotherapy for extensive-stage small cell lung cancer patients
Doctors are still figuring out the best way to treat extensive-stage small cell lung cancer
This review examines the use of thoracic radiotherapy combined with chemoimmunotherapy in patients with extensive-stage small cell lung canc…
A review notes that while combining radiation with chemotherapy and immune therapy helps some patients, the best approach is still being stu…
First-line platinum-based chemotherapy associated with disease control and survival in recurrent NSCLC patients
Chemotherapy Changes Your Immune Cells
This cohort study evaluated 42 patients with recurrent unresectable locally advanced or stage IV NSCLC without actionable mutations receivin…
Standard lung cancer chemotherapy can reshape the body's immune defenses instead of just destroying them, helping patients control their dis…